Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

BBH vs FBIOX overlap: 36% of top holdings shared

Bottom line

How much do BBH and FBIOX overlap?

36% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 56.7% of BBH's assets and 24.7% of FBIOX's. They share a meaningful core but differ in the rest of the portfolio.

FBIOX holds far more positions (215 vs 25), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

BBHFBIOX
Weight overlap (top 25)36%
Shared holdings9
Weight in shared holdings56.7%24.7%
Total positions25215
Expense ratio0.35%0.62%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings BBH and FBIOX have in common

Holding% of BBH% of FBIOXOverlap
Amgen Inc15.25%6.53%6.53%
Gilead Sciences Inc12.79%4.82%4.82%
Revolution Medicines Inc5.27%2.02%2.02%
Argenx SE4.97%2.25%2.25%
Natera Inc4.92%1.41%1.41%
Alnylam Pharmaceuticals Inc3.83%2.93%2.93%
Biogen Inc3.63%1.26%1.26%
Moderna Inc3.36%1.28%1.28%
Insmed Inc2.67%2.25%2.25%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in BBH

  1. Vertex Pharmaceuticals Inc — 9.10%
  2. Regeneron Pharmaceuticals Inc — 6.21%
  3. IQVIA Holdings Inc — 4.31%
  4. Illumina Inc — 3.17%
  5. United Therapeutics Corp — 2.83%
  6. BeOne Medicines Ltd — 2.81%
  7. Incyte Corp — 2.49%
  8. Neurocrine Biosciences Inc — 2.08%
  9. BioNTech SE — 1.94%
  10. Icon Plc — 1.90%
  11. Bio-Techne Corp — 1.54%
  12. Charles River Laboratories International Inc — 1.50%
  13. BioMarin Pharmaceutical Inc — 1.34%
  14. Qiagen Nv — 1.06%
  15. Tempus AI Inc — 0.98%

Only in FBIOX

  1. Krystal Biotech Inc — 10.58%
  2. Abbvie Inc — 9.22%
  3. Fidelity Revere Street Trust — 3.35%
  4. Praxis Precision Medicines Inc. — 2.47%
  5. Ascendis Pharma A/s — 2.04%
  6. Ucb Sa — 2.00%
  7. Jazz Pharmaceuticals Plc — 1.84%
  8. Scholar Rock Holding Corp — 1.55%
  9. Axsome Therapeutics Inc — 1.28%
  10. Protagonist Therapeutics Inc — 1.15%
  11. Roivant Sciences Ltd — 1.13%
  12. Cogent Biosciences Inc — 1.07%
  13. Tango Therapeutics Inc — 0.98%
  14. Celcuity Inc — 0.95%
  15. Madrigal Pharmaceuticals Inc — 0.93%

Asset mix

Asset typeBBHFBIOX
Stocks100.0%99.0%
Cash & short-term funds0.1%3.5%
Preferred stock—0.9%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryBBHFBIOX
US87.3%88.5%
NL6.0%2.9%
CH2.8%1.1%
DK—2.6%
BE—2.0%
IE1.9%2.0%
DE1.9%—
BM—1.1%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do BBH and FBIOX overlap?
About 36% by weight. 9 securities appear in both funds' top 25 holdings; they make up 56.7% of BBH's assets and 24.7% of FBIOX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do BBH and FBIOX have in common?
The largest shared holdings are Amgen Inc, Gilead Sciences Inc, Alnylam Pharmaceuticals Inc, Insmed Inc, Argenx SE.
Should I own both BBH and FBIOX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, BBH or FBIOX?
FBIOX is broader, with 215 positions versus 25 for BBH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.